Table 1.
Description | Benefit vs. Risk and Burdens | Methodologic Quality of Supporting Evidence | Implications | |
---|---|---|---|---|
1A | Strong recommendation, High quality evidence |
Benefits clearly outweigh risk and burdens or vice versa | RCTs without important limitations or overwhelming evidence from observational studies | Strong recommendation, can apply to most patients in most circumstances without reservation |
1B | Strong recommendation, Moderate quality evidence |
Benefits clearly outweigh risk and burdens or vice versa | RCTs with important limitations (inconsistent results, methodologic flaws, indirect or imprecise) or exceptionally strong evidence from observational studies | Strong recommendation, can apply to most patients in most circumstances without reservation |
1C | Strong recommendation, Low or very low quality evidence |
Benefits clearly outweigh risk and burdens or vice versa | Observational studies or case series | Strong recommendation but may change when higher quality evidence becomes available |
2A | Weak recommendation, High quality evidence |
Benefits closely balanced with risks and burdens | RCTs without important limitations or overwhelming evidence from observational studies | Weak recommendation, best action may differ depending on circumstances or patients’ or societal values |
2B | Weak recommendations, Moderate quality evidence |
Benefits closely balanced with risks and burdens | RCTs with important limitations (inconsistent results, methodologic flaws, indirect or imprecise) or exceptionally strong evidence from observational studies | Weak recommendation, best action may differ depending on circumstances or patients’ or societal values |
2C | Weak recommendation, Low or very low quality evidence |
Uncertainty in the estimates of benefits, risks and burden; benefits, risk and burden may be closely balanced | Observational studies or case series | Very weak recommendations; other alternatives may be equally reasonable |
GRADE = Grades of Recommendation, Assessment, Development, and Evaluation; RCT = randomized controlled trial. Adapted from Guyatt G, Gutermen D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest. 2006;129:174-181. Used with permission